Dr Antoine Hollebecque

Spécialité

Oncologue médical, expert colon, estomac, foie et pancréas

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma. (12 août 2025)
• From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology. (1 août 2025)
• Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. (31 juil. 2025)
• Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. (30 juil. 2025)
• Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. (7 juin 2025)